Policy and Practice Strategies to Address the Clinical Practice Gaps Affecting the Implementation of Personalized Medicine in Cancer Care
Co-Organized with Personalized Medicine Coalition (PMC)
Daryl Pritchard, PhD, Senior Vice President, Science Policy, Personalized Medicine Coalition
Robert H. Dumanois, Director, Reimbursement Strategy, Thermo Fisher Scientific
Anthony N. Sireci, MD, MSc, Senior Vice President, Clinical Biomarkers & Diagnostics Division, Loxo Oncology, Inc.
Apostolia-Maria Tsimberidou, MD, PhD, FASCO, FAASS, Professor of Medicine, Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center